Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

B4388

Sigma-Aldrich

2-Bromo-2-chloro-1,1,1-trifluoroethane

≥99%

Synonym(s):

Halothane

Sign Into View Organizational & Contract Pricing

Select a Size

125 ML
$161.00
250 ML
$224.00

$161.00

Check Cart for Availability
All Photos(1)

Select a Size

Change View
125 ML
$161.00
250 ML
$224.00

About This Item

Linear Formula:
BrCH(Cl)CF3
CAS Number:
151-67-7
Molecular Weight:
197.38
Beilstein/REAXYS Number:
1736947
EC Number:
205-796-5
MDL number:
MFCD00009602
UNSPSC Code:
12352202
PubChem Substance ID:
24891772
NACRES:
NA.77

$161.00

Check Cart for Availability

vapor pressure

4.5 psi ( 20 °C)

Quality Level

200

assay

≥99%

form

liquid

contains

0.01% thymol as stabilizer

refractive index

n20/D 1.369 (lit.)

bp

50.2 °C (lit.)

density

1.872 g/mL at 25 °C (lit.)

SMILES string

FC(F)(F)C(Cl)Br

InChI

1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H

InChI key

BCQZXOMGPXTTIC-UHFFFAOYSA-N

Gene Information

human ... ATP5D(513) , GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879) , GLRA1(2741) , GLRB(2743) , GRIA1(2890) , KCNK10(54207) , KCNK18(338567) , KCNK2(3776) , KCNK3(3777) , KCNK9(51305) , KCNN4(3783)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

2-Bromo-2-chloro-1,1,1-trifluoroethane, or halothane, has been used in a study that combined molecular simulations with free energy simulations to study solvation of halothane in polarizable water and methanol. Halothane has also been used in a study to investigate the interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor.

Biochem/physiol Actions

2-Bromo-2-chloro-1,1,1-trifluoroethane is an inhalation anesthetic. In an effect believed to be independent of anesthesia, halothane inhibits the synthesis of 5-hydroxytryptamine in brain tissue, probably at the tryptophan hydroxylase step.
Inhalation anesthetic.

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Repr. 1B - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBJ9134
STBH5039
MKBR5800V
MKBR0402V
SLBD2414V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

G I Elmer et al.
Behavioural brain research, 359, 950-957 (2018-06-23)
A growing body of clinical and preclinical research suggests that structural and functional changes in the habenula, a component of the epithalamus, are associated with major depressive disorder. A major excitatory, efferent projection from the habenula targets the rostromedial tegmentum
Mala Chakraborty et al.
Hepatology (Baltimore, Md.), 62(2), 546-557 (2015-02-26)
Clinical evidence suggests that many cases of serious idiosyncratic drug-induced liver injury are mediated by the adaptive immune system in response to hepatic drug-protein adducts, also referred to as "drug-induced allergic hepatitis"; but detailed mechanistic proof has remained elusive due
Samina Salim et al.
Behavioural brain research, 208(2), 545-552 (2010-01-13)
Recent work has suggested correlation of oxidative stress with anxiety-like behavior. There also is evidence for anxiolytic effects of physical exercise. However, a direct role of oxidative stress in anxiety is not clear and a protective role of physical exercise
T Russell et al.
Anaesthesia, 67(9), 1021-1024 (2012-06-28)
We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50
Jason T Moore et al.
Current biology : CB, 22(21), 2008-2016 (2012-10-30)
Despite seventeen decades of continuous clinical use, the neuronal mechanisms through which volatile anesthetics act to produce unconsciousness remain obscure. One emerging possibility is that anesthetics exert their hypnotic effects by hijacking endogenous arousal circuits. A key sleep-promoting component of
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service